AO

Achamma Oomman

Director Director DIN 02637637
DIN 02637637 First appointment Jun 2005 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Jun 2005
Shareholding value Locked Premium profile

About Achamma Oomman

Data last updated:

Achamma Oomman has 21 years in corporate governance. Formerly with 1 company, such as Nutragen Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 02637637
Primary Designation Director
First Appointment 10 Jun 2005
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedStatus
Nutragen Pharma Private Limited U24232TN2005PTC056577
Director10 Jun 20052005Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Nutragen Pharma Private Limited
Premium access

Shareholding and investment profile for Achamma Oomman

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Achamma Oomman

Achamma Oomman has 21 years in corporate governance. Formerly with 1 company, such as Nutragen Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.

Achamma Oomman is associated with 0 companies as a director.

Achamma Oomman has expertise in General Business.

Achamma Oomman has 21 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available